KeyBanc keeps InnovAge at Overweight; price target raised to $14
KeyBanc maintained InnovAge at Overweight and raised its price target to $14.00 per share from $13.00,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.